Powder: -20°C for 3 years | In solvent: -80°C for 1 year
B220, an antiviral agent, inhibits the growth of HSV-1, HSV-2, and human cytomegalovirus (CMV).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 297.00 | |
5 mg | In stock | $ 745.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | In stock | $ 1,490.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,760.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 737.00 |
Description | B220, an antiviral agent, inhibits the growth of HSV-1, HSV-2, and human cytomegalovirus (CMV). |
In vitro | B220 inhibits the neutrophil release of reactive oxygen species, as well as the intracellular generation of reactive oxygen species. The inhibition is not achieved through direct oxygen radical scavenger activity of B220, and B220 has no immediate effects on the activity of the assembled oxidase. The neutrophil capability to phagocytose fluorescein-labeled opsonized yeast cells is reduced by B220. Cells preincubated with B220 (10 µg/mL) and then stimulated with the formylated peptide fMLP mobilize fewer C3 receptors on their surface than the control cells [2]. |
Molecular Weight | 318.42 |
Formula | C20H22N4 |
CAS No. | 112228-65-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 9 mg/mL (28.26 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
B220 112228-65-6 Microbiology/Virology HSV B-220 B 220 inhibitor inhibit